Derivative Instruments and Hedging Activities

6 Months Ended

Dec. 31, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of December 31, 2015, June 27, 2015, and June 28, 2014. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.     

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense. All of our interest rate swaps qualify for hedge accounting treatment.

During the six months endedDecember 31, 2015, we entered into a forward interest rate swap to hedge against changes in the benchmark interest rate between the date the interest rate swap was entered into and the date of expected future debt issuance. The interest rate swap was designated as a cash flow hedge and had a notional amount totaling $200.0 million.

We had a $300.0 million term loan with floating interest rates priced off the LIBOR yield curve, which was repaid during the fiscal year endedJune 27, 2015, as described in Note 10. As a result of the term loan repayment on June 24, 2015, the forward interest rate swap agreements with notional amounts totaling $240.0 million that were in place to hedge the change in the LIBOR rate were terminated as well. We recorded a loss of $3.6 million in Other expense, net, during the fiscal year endedJune 27, 2015 for the amount remaining in AOCI when the hedges were terminated.

In connection with the Omega acquisition, we assumed a $20.0 million private placement note. We also assumed an interest rate swap agreement with a notional amount totaling $20.0 million that was in place to hedge the cross currency exchange differences between the U.S. dollar and the euro on the above-mentioned debt. On May 29, 2015, we repaid the loan and the interest rate swap. We also assumed €500.0 million ($544.5 million) of debt under Omega's revolving credit facility, as well as an interest rate swap agreement with a notional amount of €135.0 million ($147.0 million) that was in place to hedge the change in the floating rate on that credit facility. On April 8, 2015, we repaid the loan and terminated the interest rate swap. Because both interest rate swaps mentioned above were recorded at fair market value on the date of termination, no gain or loss was recorded. For more information on the acquired debt and termination, see Note 10.

During the three months endedDecember 27, 2014, we entered into forward interest rate swaps and treasury locks (together "Rate Locks") to hedge against changes in the interest rates between the date the Rate Locks were entered into and the date of the issuance of our 2014 Bonds, discussed in Note 10. These Rate Locks were designated as cash flow hedges of expected future debt issuances with a notional amount totaling $750.0 million. The Rate Locks were settled upon the issuance of an aggregate $1.6 billion principal amount of our 2014 Bonds on December 2, 2014 for a cumulative after-tax loss of $5.8 million in OCI after recording $1.1 million of ineffectiveness to Other expense, net, during the fiscal year endedJune 27, 2015.

During the three months ended September 28, 2013, we entered into forward interest rate swap agreements to hedge against changes in the benchmark interest rate between the date the swap agreements were entered into and the date of the issuance of our 2013 Bonds, discussed in Note 10. These swaps were designated as cash flow hedges of expected future debt issuances with a notional amount totaling $725.0 million. The interest rate swaps were settled upon the issuance of an aggregate $2.3 billion principal amount of our 2013 Bonds on December 18, 2013 for a cumulative after-tax loss of $12.8 million in OCI after recording $0.5 million of ineffectiveness to Other expense, net, during the fiscal year endedJune 28, 2014.

In addition, due to the retirement of the underlying private placement senior notes (described in Note 10 as the "Private Placement Notes")on December 23, 2013, we wrote off the amounts remaining in AOCI associated with the cash flow hedges related to the Private Placement Notes, resulting in an after-tax loss of $2.6 million recorded to Other expense, net, during the fiscal year endedJune 28, 2014.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $755.5 million, $452.3 million, and $228.5 million as of December 31, 2015, June 27, 2015, and June 28, 2014, respectively.

In June 2015, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated GSK acquisition discussed in Note 2, we entered into a non-designated option contract to protect against a strengthening of the euro relative to the U.S. dollar. We recorded losses of $1.9 million for the change in fair value of the option contract during the fiscal year endedJune 27, 2015 in Other expense, net. Because these derivatives were economically hedging a future acquisition, the cash outflow associated with their settlement is shown as an investing activity on the Consolidated Statements of Cash Flows. The GSK acquisition closed on August 28, 2015 and therefore, the non-designated option contract was terminated.

In November 2014, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price of Omega, we entered into non-designated option contracts with a total notional amount of €2.0 billion. The option contracts settled in December 2014, resulting in a loss of $26.4 million. The option contracts were replaced with non-designated forward contracts that matured during the three months ended March 28, 2015. We recorded losses of $298.1 million during the fiscal year endedJune 27, 2015 related to the settlement of the forward contracts.Both losses were recorded primarily in Other expense, net. The losses on the derivatives due to changes in the euro to U.S. dollar exchange rates were economically offset at closing in the final settlement of the euro-denominated Omega purchase price. Because these derivatives were economically hedging a future acquisition, the cash outflow associated with their settlement is shown as an investing activity on the Consolidated Statements of Cash Flows.

Fair Value Hedges

During the three months ended September 28, 2013, we entered into three pay-floating interest rate swaps with a total notional amount of $425.0 million to hedge changes in the fair value of our private placement notes from fluctuations in interest rates. These swaps were designated and qualified as fair value hedges of our fixed rate debt. Accordingly, the gain or loss recorded on the pay-floating interest rate swaps was directly offset by the change in fair value of the underlying debt. Both the derivative instrument and the underlying debt were adjusted to market value at the end of each period with any resulting gain or loss recorded in Other expense, net. The hedge was terminated during the three months ended December 28, 2013 due to the retirement of the underlying notes.

Effects of Derivatives on the Financial Statements

The below tables indicate the effects of all of our derivative instruments on our consolidated financial statements. All amounts are shown gross of income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:

	Asset Derivatives
		Fair Value
	Balance Sheet Location	December 31, 2015		June 27, 2015		June 28, 2014
Designated derivatives:
Foreign currency forward contracts	Other current assets	$	3.8	$	3.3	$	2.8
Total designated derivatives		$	3.8	$	3.3	$	2.8
Non-designated derivatives:
Foreign currency forward contracts	Other current assets	$	1.0	$	9.1	$	0.3
Total non-designated derivatives		$	1.0	$	9.1	$	0.3

	Liability Derivatives
		Fair Value
	Balance Sheet Location	December 31, 2015		June 27, 2015		June 28, 2014
Designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	2.0	$	2.0	$	0.7
Interest rate swap agreements	Other non-current liabilities	0.3		—		8.3
Total designated derivatives		$	2.3	$	2.0	$	9.0
Non-designated derivatives:
Foreign currency forward contracts	Accrued liabilities	$	1.9	$	2.6	$	0.1
Total non-designated derivatives		$	1.9	$	2.6	$	0.1

The gains (losses) recognized in OCI for the effective portion of our designated cash flow hedges were as follows:

	Amount of Gain/(Loss) Recorded in OCI (Effective Portion)
	Six Months Ended			Fiscal Year Ended
Designated Cash Flow Hedges	December 31, 2015			June 27, 2015			June 28, 2014		June 29, 2013
Treasury locks	$	—		$	(2.7	)	$	—	$	—
Interest rate swap agreements	(0.3		)	(10.1		)	7.2		(1.3		)
Foreign currency forward contracts	1.7			(7.7		)	15.1		(10.6		)
	$	1.4		$	(20.5	)	$	22.3	$	(11.9	)

The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:

		Amount of Gain/(Loss) Reclassified from AOCI to Income (Effective Portion)
		Six Months Ended			Fiscal Year Ended
Designated Cash Flow Hedges	Income Statement Location	December 31, 2015			June 27, 2015			June 28, 2014			June 29, 2013
Treasury locks	Interest expense, net	$	—		$	(0.1	)	$	0.2		$	(0.4	)
Interest rate swap agreements	Interest expense, net	(0.8		)	(16.4		)	3.9			5.0
Foreign currency forward contracts	Net sales	(0.8		)	2.0			(2.5		)	(2.9		)
	Cost of sales	0.8			(4.2		)	(6.3		)	4.3
	Interest expense, net	(0.4		)	—			(0.2		)	(0.1		)
	Other expense, net	0.1			(4.5		)	(2.2		)	(3.2		)
		$	(1.1	)	$	(23.2	)	$	(7.1	)	$	2.7

The net of tax amount expected to be reclassified out of AOCI into earnings during the next 12 months is a $0.4 million gain.

The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:

		Amount of Gain/(Loss) Recognized in Income (Ineffective Portion)
		Six Months Ended			Fiscal Year Ended
Designated Cash Flow Hedges	Income Statement Location	December 31, 2015			June 27, 2015			June 28, 2014			June 29, 2013
Treasury locks	Other expense, net	$	—		$	(0.4	)	$	2.3		$	—
Interest rate swap agreements	Other expense, net	—			(0.7		)	(5.4		)	—
Foreign currency forward contracts	Net sales	(0.1		)	(0.1		)	(0.1		)	—
	Cost of sales	0.2			0.2			0.3			0.2
Total		$	0.1		$	(1.0	)	$	(2.9	)	$	0.2

The effects of our fair value hedges on the Consolidated Statements of Operations were as follows:

		Amount of Gain/(Loss) Recognized in Income
		Six Months Ended		Fiscal Year Ended
Designated Fair Value Hedges	Income Statement Location	December 31, 2015		June 27, 2015		June 28, 2014			June 29, 2013
Interest rate swap agreements	Other expense, net	$	—	$	—	$	0.9		$	—
Fixed-rate debt	Other expense, net	—		—		(4.1		)	—
Net hedge		$	—	$	—	$	(3.2	)	$	—

The effects of our non-designated derivatives on the Consolidated Statements of Operations were as follows:

		Amount of Gain/(Loss) Recognized in Income
		Six Months Ended			Fiscal Year Ended
Non-Designated Derivatives	Income Statement Location	December 31, 2015			June 27, 2015			June 28, 2014			June 29, 2013
Foreign currency forward contracts	Other expense, net	$	(8.0	)	$	(295.4	)	$	(0.1	)	$	4.7
	Interest expense, net	(0.7		)	(3.4		)	—			—
Foreign exchange option contracts	Other expense, net	—			(26.4		)	—			—
Total		$	(8.7	)	$	(325.2	)	$	(0.1	)	$	4.7

Derivatives, Policy [Policy Text Block]

Derivative Instruments

We record derivative instruments on the balance sheet on a gross basis as either an asset or liability measured at fair value. See Note 8 for a table indicating where each component is recorded on the Consolidated Balance Sheets. Additionally, changes in a derivative's fair value, which are measured at the end of each period, are recognized in earnings unless specific hedge accounting criteria are met. If hedge accounting criteria are met for cash flow hedges, the changes in a derivative’s fair value are recorded in shareholders’ equity as a component of other comprehensive income ("OCI"), net of tax. These deferred gains and losses are recognized in income in the period in which the hedged item and hedging instrument affect earnings. Any ineffective portion of the change in fair value is immediately recognized in earnings.

We are exposed to credit loss in the event of nonperformance by the counterparties on derivative contracts. It is our policy to manage our credit risk on these transactions by dealing only with financial institutions having a long-term credit rating of "A" or better and by distributing the contracts among several financial institutions to diversify credit concentration risk. Should a counterparty default, our maximum exposure to loss is the asset balance of the instrument. The maximum term of the forward currency exchange contracts at December 31, 2015, June 27, 2015, and June 28, 2014 was 15 months.

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of December 31, 2015, June 27, 2015, and June 28, 2014. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings, recorded in Other expense, net. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.